Surfactant replacement therapy in newborns with hyaline membrane disease.
This article discusses the use of surfactant replacement therapy in the management of neonates with hyaline membrane disease (HMD). Included is an overview of HMD, current treatment modalities, a case presentation, nursing implications for managing the infant with HMD, and a nursing care plan. Administration of surfactant is discussed, along with implications for nursing research.
Grobman
D W
DW
Foley
M M
MM
D003422:Critical Care; D006801:Humans; D006819:Hyaline Membrane Disease / Q000188:drug therapy* / Q000451:nursing; D007231:Infant, Newborn; D008297:Male; D017283:Neonatal Nursing / Q000379:methods*; D010347:Patient Care Planning; D011663:Pulmonary Surfactants / Q000627:therapeutic use*
D011663:Pulmonary Surfactants